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Drug-induced liver injury (DILI) involving the adaptive
immune system is a serious complication in both patient
treatment and drug development. Flucloxacillin, a
-lactam antibiotic effective against -lactamase-producing
bacteria, is a common cause of immunological DILI
through cholestasis. We have recently isolated CD8+
flucloxacillin-specific T-cells from patients with DILI,
which indicates that T-cells participate in the pathogen-
esis of the disease. There are currently no animal models
of DILI where the adaptive immune system has shown to
damage liver, and therefore, it is difficult to explore the
mechanistic basis of the tissue injury. Thus, the aim of
this study was to use C57/Bl6 CD4 deficient mice with a
mutation in the gene encoding for MHC class II mole-
cules to explore the immunogenicity of flucloxacillin and
whether flucloxacillin-responsive CD8+ T-cells damage
hepatocytes. In initial experiments sensitization was
achieved through epicutaneous application (1g/ml; in
70% DMSO; 50L). Proliferation, IFN- and granzyme-B
secretion from draining lymph node cells was measured
ex vivo following treatment with flucloxacillin. Flucloxa-
cillin-specific CD8+ T-cell mediated killing of hepato-
cytes was measured using the ApoTox-Glo kit (Promega,
UK). In separate experiments, flucloxacillin-specific
T-cells were forced to migrate to the mesenteric lymph
nodes using retinoic acid, prior to administration of oral
flucloxacillin for 10 days, followed by analysis of plasma
biomarkers of liver injury. CD8+ T-cells from draining
lymph nodes of flucloxacillin-treated mice proliferated in
a concentration-dependent manner following ex vivo sec-
ondary stimulation. The proliferative response was asso-
ciated with IFN- and granzyme-B secretion. In contrast,
proliferative responses and cytokine secretion was not
detected with cells from vehicle control mice. Flucloxacil-
lin-specific hepatocyte toxicity and apoptosis was
observed when CD8+ T-cells were cultured with dendri-
tic cells and flucloxacillin for 24h, washed and transferred
to the hepatocyte cultures. Flucloxacillin sensitization
followed by 10 day oral exposure resulted in marked gall
bladder swelling and mild elevations in ALT. Other
plasma biomarkers of liver damage were negative. In con-
clusion, these data show successful sensitization of mice
against flucloxacillin. Thus, the C57/Bl6 CD4 deficient
mouse represents a promising model to study the role of
the adaptive immune system in DILI.
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